Lipid abnormalities in children: Should we be doing more?

Medical Journal of Australia

Volumn 190, Issue 3, 2009, Pages 107-108

  Ayer, Julian G ^a   Sullivan, David R ^b   Sholler, Gary F ^a,c  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DRUG EFFICACY; DRUG SAFETY; DYSLIPIDEMIA; EDITORIAL; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY HISTORY; FETOTOXICITY; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIPID ANALYSIS; LOW FAT DIET; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PREVALENCE; RISK ASSESSMENT; RISK REDUCTION; TERATOGENICITY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 61349193840     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2009.tb02304.x     Document Type: Editorial

References (20)

1. Daniels SR, Greer FR, Committee on Nutrition. Lipid screening and cardiovascular health in childhood. Pediatrics 2008; 122: 198-208.
2. McCrindle BW, Urbina EM, Dennison BA, et al. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation 2007; 115: 1948-1967.
3. American Academy of Pediatrics. National Cholesterol Education Program: Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 1992; 89: 525-584.
4. Berenson GS, Srinivasan SR, Bao W, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998; 338: 1650-1656.
5. Raitakari OT, Juonala M, Kähönen M, et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 2003; 290: 2277-2283.
6. Järvisalo MJ, Jartti L, Näntö-Salonen K, et al. Increased aortic intimamedia thickness: a marker of preclinical atherosclerosis in high-risk children. Circulation 2001; 104: 2943-2947.
7. Webber LS, Srinivasan SR, Wattigney WA, Berenson GS. Tracking of serum lipids and lipoproteins from childhood to adulthood. The Bogalusa Heart Study. Am J Epidemiol 1991; 133: 884-899.
8. Magnussen CG, Raitakari OT, Thomson R, et al. Utility of currently recommended pediatric dyslipidemia classifications in predicting dyslipidemia in adulthood: evidence from the Childhood Determinants of Adult Health (CDAH) study, Cardiovascular Risk in Young Finns Study, and Bogalusa Heart Study. Circulation 2008; 117: 32-42.
9. Lauer RM, Clarke WR. Use of cholesterol measurements in childhood for the prediction of adult hypercholesterolemia. The Muscatine Study. JAMA 1990; 264: 3034-3038.
10. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-1555.
11. Booth ML, Chey T, Wake M, et al. Change in the prevalence of overweight and obesity among young Australians, 1969-1997. Am J Clin Nutr 2003; 77: 29-36.
12. Jago R, Harrell JS, McMurray RG, et al. Prevalence of abnormal lipid and blood pressure values among an ethnically diverse population of eighth-grade adolescents and screening implications. Pediatrics 2006; 117: 2065-2073.
13. Denney-Wilson E, Hardy LL, Dobbins T, et al. Body mass index, waist circumference, and chronic disease risk factors in Australian adolescents. Arch Pediatr Adolesc Med 2008; 162: 566-573.
14. Obarzanek E, Hunsberger SA, Van Horn L, et al. Safety of a fat-reduced diet: the Dietary Intervention Study in Children (DISC). Pediatrics 1997; 100: 51-59.
15. Niinikoski H, Lagström H, Jokinen E, et al. Impact of repeated dietary counseling between infancy and 14 years of age on dietary intakes and serum lipids and lipoproteins: the STRIP study. Circulation 2007; 116: 1032-1040.
16. Andersen LB, Harro M, Sardinha LB, et al. Physical activity and clustered cardiovascular risk in children: a cross-sectional study (The European Youth Heart Study). Lancet 2006; 368: 299-304.
17. Woo KS, Chook P, Yu CW, et al. Effects of diet and exercise on obesity: related vascular dysfunction in children. Circulation 2004; 109: 1981-1986.
18. de Jongh S, Ose L, Szamosi T, et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin. Circulation 2002; 106: 2231-2237.
19. Kazmin A, Garcia-Bournissen F, Koren G. Risks of statin use during pregnancy: a systematic review. J Obstet Gynaecol Can 2007; 29: 906-908.
20. Edison RJ, Muenke M. Mechanistic and epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statins. Am J Med Genet A 2004; 131: 287-298.